Skip to main content
SpringerLink
Log in

Management of Intraepithelial Disease

  • Chapter
  • First Online:
Breast Cancer

  • 124k Accesses

Abstract

This chapter focuses on the surgical management of DCIS (DIN1c-DIN3). Issues in DIN management include: the type of surgery performed in terms of indications for breast conservative surgery (with or without radiation therapy), indications for mastectomy with reconstruction, margin assessment, and axillary staging.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Park CK, Li X, Starr J et al (2011) Cardiac morbidity and mortality in women with ductal carcinoma in situ of the breast treated with breast conserving therapy. Breast J 17:470–476

    Article  PubMed  Google Scholar 

  2. Wapnir IL, Dignam JJ, Fisher B et al (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103:478–488

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cuzick J, Sestack I, Pinder SE et al (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12:21–29

    Article  CAS  PubMed  Google Scholar 

  4. Farante G, Orecchia R, Luini A, Leonardi C, Zurrida S, Lissidini G, Krakobsky V, Veronesi U (2014) Are all patients with ductal carcinoma in situ of the breast candidates for radiotherapy after breast conservative treatment? Institute of European Oncology Guidelines. Breast J 20(4):431–433. doi:10.1111/tbj.12295. Epub 2014 Jun 2

    Article  PubMed  Google Scholar 

  5. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275:913–918

    Article  CAS  PubMed  Google Scholar 

  6. Bleyer A, Welch HG (2013) Effect of screening mammography on breast cancer incidence. N Engl J Med 368:679

    CAS  PubMed  Google Scholar 

  7. Baxter NN, Virnig BA, Durham SB, Tuttle TM (2004) Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96:443–448

    Article  PubMed  Google Scholar 

  8. Veronesi U, Salvadori B, Luini A et al (1995) Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer 31A:1574–1579

    Article  CAS  PubMed  Google Scholar 

  9. Fisher ER, Leeming R, Anderson S et al (1991) Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol 47:139–147

    Article  CAS  PubMed  Google Scholar 

  10. Schwartz GF, Solin L, Olivotto I et al (2000) Consensus conference on the treatment classification of ductal carcinoma in situ of the breast, April 22–25, 1999. Cancer 68:946–995

    Article  Google Scholar 

  11. Guerreri-Gonzaga A, Botteri E, Rotmensz N et al (2009) Ductal intraepithelial neoplasia: postsurgical outcome for 1267 woman cared for in one single institution over 10 years. Oncologist 14:201–212

    Article  Google Scholar 

  12. Fisher B et al (1993) Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328:1581–1586

    Article  CAS  PubMed  Google Scholar 

  13. Fisher B, Land S, Mamounas E et al (2001) Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28:400–418

    Article  CAS  PubMed  Google Scholar 

  14. Donker M, Litier S, Werutsky G et al (2013) Breast-conserving treatment with or without radiotherapy in ductal carcinoma in-situ: 15-Year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 31:4054–4059

    Article  PubMed  Google Scholar 

  15. Early Breast Cancer Trialists Collaborative Group (2010) Overview of the randomized trials in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010:162–177

    Article  Google Scholar 

  16. Hughes LL, Wang M, Page DL et al (2009) Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27:5319–5324

    Article  PubMed  PubMed Central  Google Scholar 

  17. Pang JM, Gorringe KL, Fox SB (2016) Ductal carcinoma in situ—update on risk assessment and management. Histopathology 68(1):96–109. doi:10.1111/his.12796

    Article  PubMed  Google Scholar 

  18. Toesca A, Botteri E, Lazzeroni M, Vila J, Manika A, Ballardini B, Bettarini F, Guerrieri-Gonzaga A, Bonanni B, Rotmensz N, Viale G, Veronesi P, Luini A, Veronesi U, Gentilini O (2014) Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: risk factors for ipsilateral breast tumor recurrence. Breast 23(6):829–835. doi:10.1016/j.breast.2014.08.016. Epub 2014 Sep 26

    Article  PubMed  Google Scholar 

  19. Wang SY, Shamliyan T, Virnig B, Kane R (2011) Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat 127:1e14

    Google Scholar 

  20. Rakovitch E, Pignol JP, Hanna W, Narod S, Spayne J, Nofech-Mozes S et al (2007) Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast- conserving therapy. J Clin Oncol 25:5591e6

    Article  Google Scholar 

  21. Lagios M (1995) The management of ductal carcinoma in situ: controversies in diagnosis, biology and treatment. Breast J 1(2):68–78

    Article  Google Scholar 

  22. Newman LA, Bensenhaver JM (eds) Ductal carcinoma in situ and microinvasive/borderline breast cancer. ISBN 978-1-4939-2034-1 ISBN 978-1-4939-2035-8 (eBook). Springer, New York. doi:10.1007/978-1-4939-2035-8

  23. Silverstein MJ (2003) The University of Southern California⁄Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 186:337–343

    Article  PubMed  Google Scholar 

  24. Silverstein MJ, Lagios MD, Groshen S et al (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455–1461

    Article  CAS  PubMed  Google Scholar 

  25. Kumar S, Sacchini V (2010) The surgical management of ductal carcinoma in situ. Breast J 16(Suppl 1):S49–S52. doi:10.1111/j.1524-4741.2010.01005.x

    Article  PubMed  Google Scholar 

  26. Silverstein MJ, Poller DN, Waisman JR et al (1995) Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345:1154–1157

    Article  CAS  PubMed  Google Scholar 

  27. Habel LA, Dignam JJ, Land SR, Salane M, Capra AM, Julian TB (2004) Mammographic density and breast cancer after ductal carcinoma in situ. J. Natl Cancer Inst 96:1467–1472

    Article  PubMed  PubMed Central  Google Scholar 

  28. Wang SY, Shamliyan T, Virnig BA, Kane R (2011) Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat 127:1–14

    Article  CAS  PubMed  Google Scholar 

  29. Goldhirsch A, Wood WC, Coates AS et al (2011) Strategies for subtypes- dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22:1736–1747

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Doyle AJ, Prakash S, Wang K, Cranshaw I, Taylor E, Oldfield R (2016) DCIS of the breast: the value of preoperative MRI. J Med Imaging Radiat Oncol 60(2):194–198. doi:10.1111/1754-9485.12430

    Article  PubMed  Google Scholar 

  31. Dunne C, Burke JP, Morrow M et al (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27:1615–1620

    Article  PubMed  Google Scholar 

  32. Houssami N, Macaskill P, Marinovich ML et al (2010) Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer 46:3219–3232

    Article  PubMed  Google Scholar 

  33. Edwards SB, Leitman IM, Wengrofsky AJ, Giddins MJ, Harris E, Mills CB, Fukuhara S, Cassaro S (2016) Identifying factors and techniques to decrease the positive margin rate in partial mastectomies: have we missed the mark? Breast J 22(3):303–309. doi:10.1111/tbj.12573

    Article  PubMed  Google Scholar 

  34. Solin LJ, Fourquet A, Vicini FA et al (2005) Long-term outcome after breast conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103:1137–1146

    Article  PubMed  Google Scholar 

  35. Shaikh T, Li T, Murphy CT, Zaorsky NG, Bleicher RJ, Sigurdson ER, Carlson R, Hayes SB, Anderson P (2016) Importance of surgical margin status in ductal carcinoma in situ. Clin Breast Cancer 16(4):312–318. doi:10.1016/j.clbc.2016.02.002. Feb 12. pii: S1526-8209(16)30022-2

    Article  PubMed  Google Scholar 

  36. Fisher B, Dignam J, Wolmark N et al (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441–452

    Article  CAS  PubMed  Google Scholar 

  37. Lyman GH, Temin S, Edge SB et al (2014) Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol 32(13):1365–1383

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy

    Antonio Toesca M.D.

Authors
  1. Antonio Toesca M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonio Toesca M.D. .

Editor information

Editors and Affiliations

  1. European Institutee of Oncology, Milan, Italy

    Umberto Veronesi

  2. European Institute of Oncology, Milan, Italy

    Aron Goldhirsch

  3. European Institute of Oncology, Milan, Italy

    Paolo Veronesi

  4. San Raffaele University and Research Hospital, Milano, Italy

    Oreste Davide Gentilini

  5. European Institute of Oncology, Milan, Italy

    Maria Cristina Leonardi

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Toesca, A. (2017). Management of Intraepithelial Disease. In: Veronesi, U., Goldhirsch, A., Veronesi, P., Gentilini, O., Leonardi, M. (eds) Breast Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-48848-6_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-48848-6_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-48846-2

  • Online ISBN: 978-3-319-48848-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation